ISRAEL CHEMICALS LTD | CIK:0000941221 | 3

  • Filed: 3/7/2018
  • Entity registrant name: ISRAEL CHEMICALS LTD (CIK: 0000941221)
  • Generator: SAP Disclosure Management
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/941221/000095010318003092/0000950103-18-003092-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/941221/000095010318003092/icl-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0000941221
  • Open this page in separate window: Click
  • ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory

    Note 5 - Operating Segments (cont’d)

     

    B. Operating segment data

     

     

    Specialty Solutions Segment

    Essential Minerals Segment

    Other

    activities

    Eliminations

    Consolidated

     

    $ millions

     

    For the year ended December 31, 2017

     

     

     

     

     

     

     

     

     

     

     

    Sales to external parties

    2,588

    2,789

    41

    -

    5,418

    Inter-segment sales

    62

    219

    2

    (283)

    -

    Total sales

    2,650

    3,008

    43

    (283)

    5,418

     

     

     

     

     

     

    Operating income attributable to the segments

    554

    359

    1

     

    914

    General and administrative expenses

     

     

     

     

    (261)

    Other expenses not allocated to segments and intercompany eliminations

     

     

     

     

    (24)

    Operating income

     

     

     

     

    629

     

     

     

     

     

     

    Financing expenses, net

     

     

     

     

    (124)

    Income before taxes on income

     

     

     

     

    505

     

     

     

     

     

     

    Capital expenditures

    80

    423

    1

     

    504

    Capital expenditures not allocated

     

     

     

     

    3

    Total capital expenditures

     

     

     

     

    507

     

     

     

     

     

     

    Depreciation, amortization and impairment

    111

    274

    3

     

    388

    Depreciation ,amortization and impairment not allocated

     

     

     

     

    30

    Total depreciation, amortization and impairment

     

     

     

     

    418

     


    Note 5 - Operating Segments (cont'd)

     

    B. Operating segment data (cont'd)

     

     

    Specialty Solutions Segment

    Essential Minerals Segment

    Other

    activities

    Eliminations

    Consolidated

     

    $ millions

     

    For the year ended December 31, 2016

     

     

     

     

     

     

     

     

     

     

     

    Sales to external parties

    2,493

    2,811

    59

    -

    5,363

    Inter-segment sales

    60

    225

    -

    (285)

    -

    Total sales

    2,553

    3,036

    59

    (285)

    5,363

     

     

     

     

     

     

    Operating income attributable to the segments

    534

    398

    5

     

    937

    General and administrative expenses

     

     

     

     

    (321)

    Other expenses not allocated to segments and intercompany eliminations

     

     

     

     

    (619)

    Operating loss

     

     

     

     

    (3)

     

     

     

     

     

     

    Financing expenses, net

     

     

     

     

    (132)

    Share in earnings of  equity-accounted investee

     

     

     

     

    18

    Loss before taxes on income

     

     

     

     

    (117)

     

     

     

     

     

     

    Capital expenditures

    95

    497

    1

     

    593

    Capital expenditures not allocated

     

     

     

     

    59

    Total capital expenditures

     

     

     

     

    652

     

     

     

     

     

     

    Depreciation ,amortization and impairment

    106

    292

    3

     

    401

    Depreciation, amortization and impairment not allocated

     

     

     

     

    5

    Total depreciation, amortization and impairment

     

     

     

     

    406

     


    Note 5 - Operating Segments (cont’d)

     

    B. Operating segment data (cont'd)

     

     

    Specialty Solutions Segment

    Essential Minerals Segment

    Other

    activities

    Eliminations

    Consolidated

     

    $ millions

     

    For the year ended December 31, 2015

     

     

     

     

     

     

     

     

     

     

     

    Sales to external parties

    2,319

    2,904

    182

    -

    5,405

    Inter-segment sales

    75

    211

    3

    (289)

    -

    Total sales

    2,394

    3,115

    185

    (289)

    5,405

     

     

     

     

     

     

    Operating income attributable to the segments

    451

    885

    16

     

    1,352

    General and administrative expenses

     

     

     

     

    (350)

    Other expenses not allocated to segments and intercompany eliminations

     

     

     

     

    (237)

    Operating income

     

     

     

     

    765

     

     

     

     

     

     

    Financing expenses, net

     

     

     

     

    (108)

    Share in earnings of  equity-accounted investee

     

     

     

     

    11

    Income before taxes on income

     

     

     

     

    668

     

     

     

     

     

     

    Capital expenditures

    98

    470

    2

     

    570

    Capital expenditures as a result of business combination

    145

    445

    -

     

    590

    Capital expenditures not allocated

     

     

     

     

    110

    Total capital expenditures

     

     

     

     

    1,270

     

     

     

     

     

     

    Depreciation, amortization and impairment

    145

    247

    37

     

    429

    Depreciation, amortization and impairment not allocated

     

     

     

     

    1

    Total depreciation, amortization and impairment

     

     

     

     

    430